New in Whitepapers

Regulatory Considerations for Running Foreign Clinical Trials to Substantiate US Dietary Supplement Structure Function Claims Marketed to the US Population

Read
Press Releases

KGK Science Authors 2 Primers on CBD for Elsevier ‘Nutraceuticals’ Textbook

February 8, 2021 – The second edition of Nutraceuticals: Efficacy, Safety and Toxicity by Ramesh C. Gupta has been released by Elsevier’s Academic Press, with ...

Learn More
Press Releases

KGK Science Receives Institutional Cannabis Research Licence from Health Canada

December 23, 2020 - KGK Science has received an Institutional Cannabis Research License from Health Canada pursuant to the Cannabis Act. In addition to the ...

Learn More
Press Releases

KGK Science Provides Regulatory Path-to-Market Strategy to Psyched Wellness for Functional Mushroom Extract Launch

December 9, 2020 – KGK Science has been contracted by Canadian health supplement company Psyched Wellness to provide a strategic regulatory package of services to ...

Learn More
Press Releases

KGK Science Contracted by Fluid Energy Group Ltd. for Serious Adverse Reaction Reporting

November 23, 2020 – KGK Science has been contracted by Fluid Energy Group Ltd. to provide Serious Adverse Reaction Reporting services for their Triton™ Life ...

Learn More
Press Releases

KGK Science Issued Health Canada Research License to Conduct Sensory Trials for Cannabis Products

September 22, 2020 – KGK Science (“KGK”) has received its second Cannabis Research License from Health Canada under the Cannabis Act. This latest license issued ...

Learn More
Press Releases

KGK Launches Virtual Clinical Trial to Test the Efficacy of a Natural Health Product to Ease Symptoms of COVID-19

September 21, 2020 – A KGK Science clinical trial to investigate the efficacy of a natural health product to ease the symptoms of COVID-19 has launched ...

Learn More
Press Releases

New Study Finds Relieve-R to be Safe and Effective for Pain Relief

August 28, 2020 – A recent clinical trial conducted by KGK Science has found evidence to support a natural health product, Relieve-R (formerly Pain Bloc-R), ...

Learn More
Press Releases

KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers

May 26, 2020 – KGK Science is developing a protocol with Hofseth Biocare for an accelerated phase 2 clinical trial assessing Hofseth’s CARDIO soft gels, ...

Learn More
Press Releases

Largest North American Clinical Trial on Probiotic Strains for IBS Symptoms Conducted by KGK Science

May 19, 2020 – The findings from a clinical trial conducted by KGK Science studying the impact of two single strain probiotics on the severity ...

Learn More
Press Releases

KGK Science Named Best Nutraceutical and Cannabinoid Full-Service CRO 2020 By Global Health & Pharma

April 14, 2020 – KGK Science has been recognized by the Global Health & Pharma (GHP) Medical Marijuana Awards as the Best Nutraceutical and Cannabinoid ...

Learn More
Press Releases

KGK Science President & CEO Joins International Probiotics Association Board of Directors

Najla Guthrie, President & CEO of KGK Science, has joined the International Probiotics Association (IPA) Board of Directors, effective April 2020. A global non-profit organization ...

Learn More
Press Releases

New Cannabis Research from KGK Science Published in Translational Neuroscience

Changing the Tone of Clinical Study Design in the Cannabis Industry The latest cannabis research from KGK Science has been published in the premier research ...

Learn More
Press Releases

KGK Science Clinic During COVID-19

As the status of the COVID-19 pandemic continues to evolve, KGK Science remains committed to the health and safety of our clinical trial participants and ...

Learn More
Press Releases

KGK Science Partners with Zentrela to Test Ontario Government-Funded Cannabis Impairment Device

KGK Science Partners with Zentrela to Test Ontario Government-Funded Cannabis Impairment Device KGK Science has been contracted by the Hamilton, Ontario-based neurotech firm, Zentrela Inc. ...

Learn More
Press Releases

KGK Science CEO Joins Natural Products Canada Board of Directors

KGK Science announced the appointment of its President and CEO, Najla Guthrie, to the Board of Directors for Natural Products Canada (NPC). As a leader ...

Learn More
Press Releases

KGK Science Leads the Nutraceutical Industry into a New Era of Scientific and Statistical Concepts

LONDON, ON (October 29, 2019) – A significant shift has taken place in scientific and statistical concepts in the nutraceutical space – a shift that ...

Learn More
Press Releases

KGK Science Grows with the Addition of Dr. Corey Hilmas as Chief Regulatory Officer

LONDON, ON (October 2019) – KGK Science Inc. (“KGK”) is a different company than it was in 2018. Following their acquisition by Auxly Cannabis Group Inc. ...

Learn More
Press Releases

KGK Science Secures Cannabis Research License for a Clinical Trial Sponsored by New Age Nanotech

LONDON, ON (September 10, 2019) – KGK Science Inc. (“KGK”), a subsidiary of Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“Auxly”), has been issued ...

Learn More
Press Releases

KGK Science Applauds the Efforts of Congress to Begin Removing Regulatory Hurdles for CBD

KGK SCIENCE APPLAUDS THE EFFORTS OF CONGRESS TO BEGIN REMOVING REGULATORY HURDLES FOR CBD KGK Science, the leader in providing human clinical trials and regulatory ...

Learn More
Press Releases

KGK Science Joins the Natural Products Association as a New Board Member

“The Time is Right for Us to Be a Leader at the Table in Those Board Discussions” London, ON – As part of the growth ...

Learn More
Press Releases

KGK Science Inc. Announces Appointment of Stephen Holmes to CFO/COO and Ashley ten Haaf to…

KGK SCIENCE INC. ANNOUNCES APPOINTMENTS OF STEPHEN HOLMES TO CFO &COO AND ASHLEY TEN HAAF TO DIRECTOR OF CLINICAL OPERATIONS London, Ontario, September 10, 2018 ...

Learn More
Press Releases

KGK Science Inc. Announces Appointment of Mal Evans Ph.D to Chief Scientific Officer

KGK SCIENCE INC. ANNOUNCES APPOINTMENT OF MAL EVANS PH.D TO CHIEF SCIENTIFIC OFFICER London, Ontario, August 21, 2018 – Najla Guthrie, President & CEO, of KGK Science ...

Learn More
Press Releases

ChromaDex Clinical Trial Studying NIAGEN® Well Underway, With Eight Additional Collaborative Human

IRVINE, Calif., July 20, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for ...

Learn More
Press Releases

KGK Synergize Inc. To Run Half Marathon In Support Of Vitamin Angels

LONDON, ON, NOVEMBER 14, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, will be participating ...

Learn More
Press Releases

Next Pharmaceuticals Acquires Sytrinol

SALINAS, Calif., June 4, 2013—Next Pharmaceuticals acquired the distribution rights, patents, trademarks and scientific knowledge for Sytrinol from KGK Synergize.

Learn More
Press Releases

KGK Synergize Inc. Welcomes Angela Kelly To Our Team!

LONDON, ON, FEBRUARY 1, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, is very pleased ...

Learn More
Press Releases

KGK Synergize Inc. Announces Settlement Of Its Lawsuit With Sourceone Global Partners, Inc.

LONDON, ON, January 27, 2012– KGK Synergize Inc. (“KGK”), a product development and contract research organization for the health nutrition industry, announced today the settlement ...

Learn More
Press Releases

Dr. Mal Evans Has Been Selected As The Recipient Of The 2010-2011 Wil Award

LONDON, ON, JUNE 28, 2011 –Recently, Dr. Mal Evans has been selected as the recipient of the 2010-2011 WIL Award which recognizes individuals and /or ...

Learn More
Press Releases

New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid

Read the article New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid using the link below: https://www.suna.org/download/members/unjarticles/2009/09apr/95.pdf

Learn More
Page 1 of 3

We're sorry, no results were found.

google-site-verification=ODzIjcIVmduDgyhTx98JdCy2M5Br0YEsotjjaj0hZbI